Vimarsana
Biggest News Aggregation in the World

Page 26 - Human Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Pharma Today - Breaking & Trending Today

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data - Vimarsana News

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data

/PRNewswire/ -- The leading research-driven biopharmaceutical company Boehringer Ingelheim and precision medicine software company Lifebit Biotech, Ltd....

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data - Vimarsana News

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data

Boehringer Ingelheim partners with Lifebit Biotech, Ltd. to build a scalable data, analytics, and infrastructure platform This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine LONDON, March 1, 2022 /PRNewswire/ -- The leading research-driven biopharmaceutical company Boehringer Ingelheim and precision medicine software company...

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data - Vimarsana News

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data

/PRNewswire/ -- The leading research-driven biopharmaceutical company Boehringer Ingelheim and precision medicine software company Lifebit Biotech, Ltd....

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data - Vimarsana News

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data

LONDON, March 1, 2022 /PRNewswire/ -- The leading research-driven biopharmaceutical company Boehringer Ingelheim and precision medicine software

Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial - Vimarsana News

Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial

/PRNewswire/ -- Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance®...